Activation of AKT by O-Linked N-Acetylglucosamine Induces Vascular Calcification in Diabetes Mellitus
Authors:
Open Access
- 28 March 2014
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 114 (7) , 1094-1102
Abstract
Rationale:: Vascular calcification is a serious cardiovascular complication that contributes to the increased morbidity and mortality of patients with diabetes mellitus. Hyperglycemia, a hallmark of diabetes mellitus, is associated with increased vascular calcification and increased modification of proteins by O-linked N-acetylglucosamine (O-GlcNAcylation). Objective:: We sought to determine the role of protein O-GlcNAcylation in regulating vascular calcification and the underlying mechanisms. Methods and Results:: Low-dose streptozotocin-induced diabetic mice exhibited increased aortic O-GlcNAcylation and vascular calcification, which was also associated with impaired aortic compliance in mice. Elevation of O-GlcNAcylation by administration of Thiamet-G, a potent inhibitor for O-GlcNAcase that removes O-GlcNAcylation, further accelerated vascular calcification and worsened aortic compliance of diabetic mice in vivo. Increased O-GlcNAcylation, either by Thiamet-G or O-GlcNAcase knockdown, promoted calcification of primary mouse vascular smooth muscle cells. Increased O-GlcNAcylation in diabetic arteries or in the O-GlcNAcase knockdown vascular smooth muscle cell upregulated expression of the osteogenic transcription factor Runx2 and enhanced activation of AKT. O-GlcNAcylation of AKT at two new sites, T430 and T479, promoted AKT phosphorylation, which in turn enhanced vascular smooth muscle cell calcification. Site-directed mutation of AKT at T430 and T479 decreased O-GlcNAcylation, inhibited phosphorylation of AKT at S473 and binding of mammalian target of rapamycin complex 2 to AKT, and subsequently blocked Runx2 transactivity and vascular smooth muscle cell calcification. Conclusions:: O-GlcNAcylation of AKT at 2 new sites enhanced AKT phosphorylation and activation, thus promoting vascular calcification. Our studies have identified a novel causative effect of O-GlcNAcylation in regulating vascular calcification in diabetes mellitus and uncovered a key molecular mechanism underlying O-GlcNAcylation–mediated activation of AKT.Keywords
This publication has 50 references indexed in Scilit:
- Cardiac O-GlcNAcylation blunts autophagic signaling in the diabetic heartLife Sciences, 2013
- Exercise training mitigates aberrant cardiac protein O-GlcNAcylation in streptozotocin-induced diabetic miceLife Sciences, 2013
- Relationship among coronary plaque compliance, coronary risk factors and tissue characteristics evaluated by integrated backscatter intravascular ultrasoundCardiovascular Ultrasound, 2012
- Extensive Crosstalk between O-GlcNAcylation and Phosphorylation Regulates Akt SignalingPLOS ONE, 2012
- O-linked β-N-acetylglucosamine supports p38 MAPK activation by high glucose in glomerular mesangial cellsAmerican Journal of Physiology-Endocrinology and Metabolism, 2011
- Phosphorylation of AKT: a Mutational AnalysisOncotarget, 2011
- Oxidative Stress Induces Vascular Calcification through Modulation of the Osteogenic Transcription Factor Runx2 by AKT SignalingJournal of Biological Chemistry, 2008
- Progression of Coronary Artery Calcification in Type 1 DiabetesDiabetes Care, 2003
- A nutrient-sensing pathway regulates leptin gene expression in muscle and fatNature, 1998
- Medial Artery CalcificationArteriosclerosis, Thrombosis, and Vascular Biology, 1996